165 related articles for article (PubMed ID: 15642707)
1. Central nervous system involvement in indolent lymphomas.
Spectre G; Gural A; Amir G; Lossos A; Siegal T; Paltiel O
Ann Oncol; 2005 Mar; 16(3):450-4. PubMed ID: 15642707
[TBL] [Abstract][Full Text] [Related]
2. Secondary central nervous system involvement by follicular lymphoma: case report and review of the literature.
Grupka NL; Seinfeld J; Ryder J; Lillehei KO; Kleinschmidt-Demasters BK
Surg Neurol; 2006 Jun; 65(6):590-4. PubMed ID: 16720183
[TBL] [Abstract][Full Text] [Related]
3. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of indolent non-Hodgkin lymphoma in patients with type 1 human immunodeficiency virus infection.
Levine AM; Sadeghi S; Espina B; Tulpule A; Nathwani B
Cancer; 2002 Mar; 94(5):1500-6. PubMed ID: 11920507
[TBL] [Abstract][Full Text] [Related]
5. Indolent Lymphomas That Present With Clinically Aggressive Features: A Subset of Low-Grade Lymphomas With a Behavior Inconsistent With the Histologic Diagnosis.
Cabanillas F; Rivera N; Pardo WI
Clin Lymphoma Myeloma Leuk; 2016 Oct; 16(10):550-557. PubMed ID: 27618361
[TBL] [Abstract][Full Text] [Related]
6. Central nervous system involvement by follicular lymphoma: a case report.
Paulo Malave L; Caceres W
Bol Asoc Med P R; 2010; 102(2):37-8. PubMed ID: 20939202
[TBL] [Abstract][Full Text] [Related]
7. Central nervous system involvement in patients with mantle cell lymphoma.
Oinonen R; Franssila K; Elonen E
Ann Hematol; 1999 Mar; 78(3):145-9. PubMed ID: 10211757
[TBL] [Abstract][Full Text] [Related]
8. Repeated courses of low-dose 2 × 2 Gy radiation therapy in patients with indolent B-cell non-Hodgkin lymphomas.
Saleh K; Michot JM; Schernberg A; Lazarovici J; Chahine C; Danu A; Khalife-Saleh N; Rossignol J; Ghez D; Martin V; Mazeron R; Fermé C; Boros A; Ribrag V; Girinsky T
Cancer Med; 2020 Jun; 9(11):3725-3732. PubMed ID: 32249547
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathologic characteristics and outcome of diffuse large B-cell lymphomas presenting with an associated low-grade component at diagnosis.
Ghesquières H; Berger F; Felman P; Callet-Bauchu E; Bryon PA; Traverse-Glehen A; Thieblemont C; Baseggio L; Michallet AS; Coiffier B; Salles G
J Clin Oncol; 2006 Nov; 24(33):5234-41. PubMed ID: 17043351
[TBL] [Abstract][Full Text] [Related]
10. High-dose therapy with hematopoietic cell transplantation for patients with central nervous system involvement by non-Hodgkin's lymphoma.
Alvarnas JC; Negrin RS; Horning SJ; Hu WW; Long GD; Schriber JR; Stockerl-Goldstein K; Tierney K; Wong R; Blume KG; Chao NJ
Biol Blood Marrow Transplant; 2000; 6(3A):352-8. PubMed ID: 10905773
[TBL] [Abstract][Full Text] [Related]
11. Non-Hodgkin's lymphomas in Greece according to the WHO classification of lymphoid neoplasms. A retrospective analysis of 810 cases.
Economopoulos T; Papageorgiou S; Dimopoulos MA; Pavlidis N; Tsatalas C; Symeonidis A; Foudoulakis A; Pectasides D; Rontogianni D; Rizos E; Chalkia P; Anagnostopoulos A; Melachrinou M; Papageorgiou E; Fountzilas G
Acta Haematol; 2005; 113(2):97-103. PubMed ID: 15802887
[TBL] [Abstract][Full Text] [Related]
12. Treatment of patients with high grade non-Hodgkin's lymphomas and central nervous system involvement: is radiation an essential component of therapy?
Magrath IT; Haddy TB; Adde MA
Leuk Lymphoma; 1996 Mar; 21(1-2):99-105. PubMed ID: 8907276
[TBL] [Abstract][Full Text] [Related]
13. Central nervous system involvement following diagnosis of non-Hodgkin's lymphoma: a risk model.
Hollender A; Kvaloy S; Nome O; Skovlund E; Lote K; Holte H
Ann Oncol; 2002 Jul; 13(7):1099-107. PubMed ID: 12176790
[TBL] [Abstract][Full Text] [Related]
14. High Doses of Antimetabolites Followed by High-Dose Sequential Chemoimmunotherapy and Autologous Stem-Cell Transplantation in Patients With Systemic B-Cell Lymphoma and Secondary CNS Involvement: Final Results of a Multicenter Phase II Trial.
Ferreri AJ; Donadoni G; Cabras MG; Patti C; Mian M; Zambello R; Tarella C; Di Nicola M; D'Arco AM; Doa G; Bruno-Ventre M; Assanelli A; Foppoli M; Citterio G; Fanni A; Mulè A; Caligaris-Cappio F; Ciceri F
J Clin Oncol; 2015 Nov; 33(33):3903-10. PubMed ID: 26282634
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors in 140 adult patients with non-Hodgkin's lymphoma with systemic central nervous system (CNS) involvement. A single centre analysis.
Hollender A; Kvaloy S; Lote K; Nome O; Holte H
Eur J Cancer; 2000 Sep; 36(14):1762-8. PubMed ID: 10974623
[TBL] [Abstract][Full Text] [Related]
16. Pathology with clinical correlations of primary central nervous system non-Hodgkin's lymphoma. The Massachusetts General Hospital experience 1958-1989.
Miller DC; Hochberg FH; Harris NL; Gruber ML; Louis DN; Cohen H
Cancer; 1994 Aug; 74(4):1383-97. PubMed ID: 8055462
[TBL] [Abstract][Full Text] [Related]
17. [Treatment results and the prognosis in patients with localization of non-Hodgkins-lymphoma in the central nervous system].
Paulus JA; Bos GM; Löwenberg B; Van Den Bent MJ
Ned Tijdschr Geneeskd; 1998 Oct; 142(40):2196-200. PubMed ID: 9864481
[TBL] [Abstract][Full Text] [Related]
18. Characteristic features of malignant lymphoma with central nervous system involvement.
Yoshida S; Morii K; Watanabe M; Saito T
Surg Neurol; 2000 Feb; 53(2):163-7. PubMed ID: 10713195
[TBL] [Abstract][Full Text] [Related]
19. Low-grade primary central nervous system lymphoma in immunocompetent patients.
Jahnke K; Thiel E; Schilling A; Herrlinger U; Weller M; Coupland SE; Krümpelmann U; Stein H; Korfel A
Br J Haematol; 2005 Mar; 128(5):616-24. PubMed ID: 15725082
[TBL] [Abstract][Full Text] [Related]
20. Liposomal cytarabine in the prophylaxis and treatment of CNS lymphoma: toxicity analysis in a retrospective case series study conducted at Polish Lymphoma Research Group Centers.
Jurczak W; Kroll-Balcerzak R; Giebel S; Machaczka M; Giza A; Ogórka T; Fornagiel S; Rybka J; Wróbel T; Kumiega B; Skotnicki AB; Komarnicki M
Med Oncol; 2015 Apr; 32(4):90. PubMed ID: 25716885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
